no image available Dickens & Co. "Breakthroughs in EGFR+ Lung Cancer Treatment: Dacomitinib Shines in Phase II Study" "New Hope for Patients with EGFR Mutation: Dacomitinib's Efficacy and Safety Profile in Severe Respiratory Distress" Price: 24.00€